Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $19.9M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Amgen USD 247.94B 20.06B Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Cara Therapeutics USD 30M 336M Mar/2026
Cassava Sciences USD 58M 24M Jun/2026
Eisai JPY 1.2T 219.32B Jun/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
Geron USD 653M 137M Nov/2026
J&J USD 653.61B 42.25B Sep/2026
Merck USD 375.59B 17.09B Nov/2026
Novartis USD 292.09B 51.5B Sep/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 165.52B 2.11B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026